Australia markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.3938+0.0072 (+1.86%)
At close: 04:00PM EDT
0.4000 +0.01 (+1.57%)
After hours: 07:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
9,620
10,262
1,775
7,411
4,112
Operating expenses
Research development
129,127
187,651
249,240
94,245
88,017
Selling general and administrative
53,189
90,185
53,752
37,248
27,203
Total operating expenses
182,316
277,836
302,993
131,493
115,220
Operating income or loss
-172,696
-267,574
-301,218
-124,082
-111,109
Interest expense
1,254
1,254
1,936
8,702
7,949
Total other income/expenses net
-2,110
-13,607
-3,433
-33,418
-4,358
Income before tax
-168,431
-277,653
-303,224
-162,890
-120,809
Income tax expense
-
-
0
0
-257.335
Income from continuing operations
-168,431
-279,818
-303,659
-167,475
-120,552
Net income
-168,431
-279,818
-303,659
-166,411
-119,359
Net income available to common shareholders
-168,431
-279,818
-303,659
-166,411
-119,359
Basic EPS
-
-1.17
-1.45
-1.07
-1.21
Diluted EPS
-
-1.17
-1.45
-1.07
-1.21
Basic average shares
-
238,622
208,830
155,127
98,718
Diluted average shares
-
238,622
208,830
155,127
98,718